DK1672987T3 - Forbedring af tarmens barriereintegritet - Google Patents

Forbedring af tarmens barriereintegritet

Info

Publication number: DK1672987T3
Authority: DK; Denmark
Prior art keywords: barrier integrity; improving bowel; bowel barrier; mammal; acid
Prior art date: 2004-06-22

Application number

DK04748674T

Other languages

English (en)

Inventor

Bernd Stahl

Tol Eric Alexander Van

Linette Eustachia Ma Willemsen

Christopher Beermann

Marleen Antoinette Koetsier

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-22

Filing date

2004-06-22

Publication date

2007-10-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34957849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1672987(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-06-22 Application filed by Nutricia Nv filed Critical Nutricia Nv

2007-10-01 Application granted granted Critical

2007-10-01 Publication of DK1672987T3 publication Critical patent/DK1672987T3/da

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/035—Organic compounds containing oxygen as heteroatom
- A23L29/04—Fatty acids or derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pediatric Medicine (AREA)
Immunology (AREA)
Pulmonology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Glass Compositions (AREA)

DK04748674T 2004-06-22 2004-06-22 Forbedring af tarmens barriereintegritet DK1672987T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/NL2004/000444 WO2005122790A1 (en)	2004-06-22	2004-06-22	Improvement of intestinal barrier integrity

Publications (1)

Publication Number	Publication Date
DK1672987T3 true DK1672987T3 (da)	2007-10-01

Family

ID=34957849

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK04748674T DK1672987T3 (da)	2004-06-22	2004-06-22	Forbedring af tarmens barriereintegritet
DK09158304.7T DK2100520T3 (da)	2004-06-22	2004-06-22	Forbedring af tarmbarriereintegritet
DK07108969T DK1815755T3 (da)	2004-06-22	2004-06-22	Forbedring af integritet af tarmbarrieren

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK09158304.7T DK2100520T3 (da)	2004-06-22	2004-06-22	Forbedring af tarmbarriereintegritet
DK07108969T DK1815755T3 (da)	2004-06-22	2004-06-22	Forbedring af integritet af tarmbarrieren

Country Status (20)

Country	Link
US (4)	US8252769B2 (da)
EP (3)	EP2100520B1 (da)
JP (1)	JP4903695B2 (da)
CN (1)	CN100589712C (da)
AT (2)	ATE363213T1 (da)
AU (1)	AU2004320743B2 (da)
BR (1)	BRPI0418921A (da)
CA (1)	CA2570205C (da)
CY (1)	CY1109224T1 (da)
DE (2)	DE602004006765T2 (da)
DK (3)	DK1672987T3 (da)
ES (3)	ES2431363T3 (da)
NZ (1)	NZ552166A (da)
PL (3)	PL1815755T3 (da)
PT (3)	PT1815755E (da)
RU (1)	RU2402240C2 (da)
SI (1)	SI1815755T1 (da)
UA (1)	UA81875C2 (da)
WO (1)	WO2005122790A1 (da)
ZA (1)	ZA200700138B (da)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19836339B4 (de) *	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
EP1597978A1 (en)	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en)	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
EP1723951A1 (en) †	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
PL1758469T5 (pl) *	2004-06-22	2014-01-31	Nutricia Nv	Poprawa integralności bariery u pacjentów z HIV przez zastosowanie kwasów tłuszczowych
EP1721611A1 (en) *	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
CA2537452C (en) *	2005-03-09	2013-12-24	Abbott Laboratories	Concentrated human milk fortifier liquid
EP1714660A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Uronic acid and probiotics
PL1871181T5 (pl) *	2005-04-21	2017-10-31	Nutricia Nv	Suplement odżywczy dla pacjentów z HIV
EP1776877A1 (en)	2005-10-21	2007-04-25	N.V. Nutricia	Method for stimulating the intestinal flora
WO2007058523A1 (en) *	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
PL1800675T4 (pl)	2005-12-23	2012-02-29	Nutricia Nv	Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
JP4771882B2 (ja) *	2006-07-21	2011-09-14	味の素ゼネラルフーヅ株式会社	糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
ES2525223T3 (es) *	2006-08-04	2014-12-19	Shs International Ltd.	Fórmula sin proteínas
EP1969952A1 (en) *	2007-03-07	2008-09-17	Friesland Brands B.V.	Allergen-free or dairy free LCPUFA powdered compositions and the use thereof in food products and especially infant formulas
WO2008153377A1 (en)	2007-06-15	2008-12-18	N.V. Nutricia	Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
PL2190304T3 (pl) *	2007-09-17	2012-04-30	Nutricia Nv	Preparat odżywczy o wysokiej wartości energetycznej
WO2009096772A1 (en) *	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
EP2130440A1 (en) *	2008-06-06	2009-12-09	N.V. Nutricia	Inhibiting E. sakazakii growth
AR078014A1 (es)	2008-06-13	2011-10-12	Nutricia Nv	Proceso para la fabricacion de una composicion nutricional estimuladora del sistema inmune
WO2010027258A1 (en) *	2008-09-02	2010-03-11	N.V. Nutricia	Nutritional compositions with lipid globules with a core comprising vegetable lipids and a coating comprising phospholipids or polar lipids
WO2010068086A1 (en)	2008-12-11	2010-06-17	N.V. Nutricia	Nutritional compositions with large lipid globule size
WO2010109626A1 (ja)	2009-03-26	2010-09-30	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
JP5738180B2 (ja) *	2009-03-26	2015-06-17	味の素ゼネラルフーヅ株式会社	生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
MX336032B (es) *	2009-11-12	2016-01-07	Nestec Sa	Composicion nutricional para promover el balance y salud de la microbiota intestinal.
WO2011115476A1 (en) *	2010-03-17	2011-09-22	N.V. Nutricia	Infant nutrition for improving fatty acid composition of brain membranes later in life
CN103025178B (zh) *	2010-04-26	2015-02-11	雀巢产品技术援助有限公司	用于从胃肠外营养转换至肠内营养的营养组合物和方法
JP2013535984A (ja) *	2010-08-24	2013-09-19	アボット・ラボラトリーズ	官能特性を改善した栄養製品
NZ610471A (en)	2010-11-02	2014-12-24	Abbott Lab	Stable concentrated liquid human milk fortifier
NZ611807A (en)	2010-12-31	2015-02-27	Abbott Lab	Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
DK2658549T3 (da)	2010-12-31	2020-06-29	Abbott Lab	Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
WO2012177118A1 (en)	2011-06-22	2012-12-27	N.V. Nutricia	Method for reducing the occurrence of infection in young children
PH12014500185A1 (en)	2011-07-22	2019-10-11	Abbott Lab	Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG2014013478A (en)	2011-08-29	2014-05-29	Abbott Lab	Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2014004719A (es)	2011-10-18	2015-02-05	Nestec Sa	Composicion para su uso en la promocion de la angiogenesis intestinal y de la absorcion de nutrientes y de tolerancia a la alimentacion enteral y/o en la prevencion y/o en el tratamiento de la inflamacion intestinal y/o en la recuperacion posterior a un daño o cirugia intestinal.
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
US20150305387A1 (en)	2012-12-10	2015-10-29	N.V. Nutricia	Nutritional composition with non digestible oligosaccharides
US9352020B2 (en) *	2013-03-15	2016-05-31	Mead Johnson Nutrition Company	Reducing proinflammatory response
US20160263033A1 (en)	2013-11-01	2016-09-15	N.V. Nutricia	Lipid composition for improving body composition during catch-up growth
BR112016009357B1 (pt)	2013-11-04	2021-09-14	N.V. Nutricia	Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
US9815473B2 (en)	2014-01-30	2017-11-14	Ford Global Technologies, Llc	Manual transmission clutch control using driveline measurements
CA2973536A1 (en) *	2015-01-23	2016-07-28	Nestec S.A.	Method for determining the distinctive nutritional requirements of a patient
EP3574771B1 (en)	2015-10-15	2022-11-16	N.V. Nutricia	Infant formula with special lipid architecture for promoting healthy growth
CN105231461A (zh) *	2015-10-30	2016-01-13	中营康园（北京）科技有限公司	一种提高机体免疫力的营养组合物及其应用
WO2018104512A1 (en)	2016-12-09	2018-06-14	N.V. Nutricia	Nutritional composition for improving cell membranes
KR102665545B1 (ko)	2017-04-17	2024-05-13	더 유니버서티 오브 시카고	인간 건강에의 적용 및 질환의 치료를 위한 장으로의 단쇄 지방산의 전달을 위한 중합체 재료
ES2944359T3 (es)	2017-05-12	2023-06-20	Evonik Operations Gmbh	Procedimiento de detección de enfermedades inducidas por C. perfringens en una bandada de aves
CN107198250B (zh) *	2017-05-23	2019-03-12	北京瑞千景科技发展有限公司	改善肠道微生态预防慢性病组合物和均衡营养食品及应用
WO2019166534A1 (en)	2018-03-02	2019-09-06	Evonik Degussa Gmbh	In vitro method for detecting intestinal barrier failure in animals by determining ovotransferrin
CN109527123A (zh) *	2018-12-14	2019-03-29	大连大学	一种对慢性肠炎具有改善作用的调和油
AU2020275468B2 (en)	2019-05-15	2024-06-27	N.V. Nutricia	Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
DK3883393T3 (da)	2019-06-04	2022-12-05	Nutricia Nv	Næringssammensætning omfattende 2'fucosyllactose og diætetisk butyrat
EP4286014A3 (en)	2019-06-04	2024-02-21	N.V. Nutricia	Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
PL437793A1 (pl) *	2021-05-07	2022-11-14	Uniwersytet Medyczny w Łodzi	Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
GB2608587B (en) *	2021-06-25	2025-01-01	Mjn Us Holdings Llc	Use of extensively hydrolysed protein
US20240277739A1 (en) *	2021-07-01	2024-08-22	N.V. Nutricia	Nutritonal compositions for gut barrier function

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2981629A (en) *	1960-04-05	1961-04-25	Lewis F Ginnette	Process of dehydrating foams
DE2033677A1 (de)	1970-07-07	1972-02-17	Deutsche Laevosan Gesellschaft C F Boehringer & Sohne GmbH & Co KG, Suddeutsche Zucker AG, 6800 Mannheim	Arzneimittel
US4237118A (en) *	1972-03-06	1980-12-02	Howard Alan N	Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (da) *	1973-05-21	1981-10-29
JPS5263224A (en)	1975-11-20	1977-05-25	Asahi Chem Ind Co Ltd	Resin compositions for coating powder with low-temperature curing prop erty
JPS5342340A (en)	1976-09-29	1978-04-17	Shin Kobe Electric Machinery	Method of producing battery plate
DE2844861A1 (de)	1978-10-14	1980-04-30	Kerstein Pharma Hameln Gmbh	Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
FR2490496A1 (fr) *	1980-09-19	1982-03-26	Roussel Uclaf	Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) *	1982-06-25	1984-03-20	Societe D'assistance Technique Pour Produits Nestle S.A.	Foaming creamer and method of making same
US4859488A (en)	1987-09-15	1989-08-22	Kabushiki Kaisha Yakult Honsha	Liquid food for curing constipation: polydextrose and oligosaccharide
DE3734962C1 (de)	1987-10-15	1989-01-05	Luitpold Werk Chem Pharm	Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
IE61565B1 (en)	1988-08-24	1994-11-16	Akzo Nv	Heparin fragments and fractions with anti-HIV action
JP2782443B2 (ja) *	1988-12-26	1998-07-30	將純吉原	抗エイズウィルス剤
DE3901048A1 (de)	1989-01-14	1990-07-19	Chimicasa Gmbh	Antikachectikum
JP2779963B2 (ja)	1989-02-09	1998-07-23	株式会社林原生物化学研究所	ビフィズス菌増殖促進剤
JPH02286058A (ja)	1989-04-28	1990-11-26	Nippon Synthetic Chem Ind Co Ltd:The	整腸剤
ES2033193B1 (es) *	1990-10-30	1994-01-16	Ganadera Union Ind Agro	Mezcla grasa para nutricion infantil y de adultos.
BR9205526A (pt) *	1991-01-24	1994-04-19	Martek Corp Sociedade Norte Am	Misturas de oleos microbianos e usos dos mesmos
FR2673812B1 (fr)	1991-03-13	1994-04-01	Roussel Uclaf	Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9109125D0 (en)	1991-04-27	1991-06-12	Cerestar Holding Bv	Sweetening composition
IT1248060B (it)	1991-06-14	1995-01-05	Italfarmaco Spa	Eparine acilate come inibitori della replicazione di retrovirus
GB9116054D0 (en)	1991-07-24	1991-09-11	Efamol Holdings	Preparation of fatty acid medicaments
US5629023A (en) *	1991-12-31	1997-05-13	Bland; Jeffrey S.	Medical food composition for metabolic detoxification
WO1993020718A1 (en)	1992-04-10	1993-10-28	Otsuka Pharmaceutical Co., Ltd.	Food composition which inhibits formation of intestinal putrefaction product
CA2089607C (en)	1992-11-05	1997-11-04	Ranjit K. Chandra	Nutritional supplement for the elderly
US5372852A (en) *	1992-11-25	1994-12-13	Tektronix, Inc.	Indirect printing process for applying selective phase change ink compositions to substrates
US5502041A (en) *	1992-12-11	1996-03-26	The Center For Innovative Technology	Potent inhibitor of HIV reverse transcriptase
GB9304746D0 (en)	1993-03-09	1993-04-28	Scotia Holdings Plc	Treatment of viral infections
US5472952A (en) *	1993-03-18	1995-12-05	Bristol-Myers Squibb Company	Partially hydrolyzed pectin in nutritional compositions
US5405637A (en)	1993-06-30	1995-04-11	Bristol-Myers Squibb Company	Milk protein partial hydrolysate and infant formula containing same
GB9318611D0 (en)	1993-09-08	1993-10-27	Sandoz Nutrition Ltd	Improvements in or relating to organic compounds
JP3310738B2 (ja) *	1993-11-10	2002-08-05	株式会社ロッテ	低カロリーチョコレート
DE4404877C1 (de) *	1994-02-17	1995-03-02	Ksk Industrielackierungen Gmbh	Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
PT754001E (pt)	1994-04-01	2002-07-31	Abbott Lab	Produto nutricional para tratamento da colite ulcerosa e sua utilizacao
US5952314A (en) *	1994-04-01	1999-09-14	Demichele; Stephen Joseph	Nutritional product for a person having ulcerative colitis
US5444054A (en) *	1994-04-01	1995-08-22	Abbott Labatories	Method of treating ulcerative colitis
EP0692252B1 (en)	1994-06-14	2001-04-04	"Raffinerie Tirlemontoise", société anonyme:	Use of a composition containing inulin or oligofructose in cancer treatment
JP3419897B2 (ja) *	1994-07-22	2003-06-23	明治乳業株式会社	低アレルギー性調製乳
NL9401644A (nl)	1994-10-06	1996-05-01	Friesland Brands Bv	Voedingsmiddel voor zwangere en lacterende vrouwen
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
US5531988A (en) *	1994-10-28	1996-07-02	Metagenics, Inc.	Bacteria and immunoglobulin-containing composition for human gastrointestinal health
EP0711503A3 (en)	1994-11-14	1997-11-26	Scotia Holdings Plc	Milk fortified with GLA and/or DGLA
JPH08151328A (ja)	1994-11-28	1996-06-11	Fuji Ratetsukusu Kk	エイズ感染防止潤滑剤
US5733579A (en) *	1995-04-05	1998-03-31	Abbott Laboratories	Oral rehydration solution containing indigestible oligosaccharides
US6099871A (en)	1995-06-01	2000-08-08	Bristol-Myers Squibb Company	Anti-regurgitation infant formula
US20020016289A1 (en) *	1995-06-01	2002-02-07	Orla M. Conneely	Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en)	1995-07-11	1998-10-27	Abbott Laboratories	Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
ES2123903T5 (es) *	1995-08-04	2011-02-22	N.V. Nutricia	Composición nutritiva conteniendo fibra.
JPH0965855A (ja)	1995-08-28	1997-03-11	Otsuka Shokuhin Kk	低カロリー整腸食品素材
MY115050A (en) *	1995-10-16	2003-03-31	Mead Johnson Nutrition Co	Diabetic nutritional product having controlled absorption of carbohydrate
AUPN881396A0 (en)	1996-03-20	1996-04-18	Arnott's Biscuits Limited	Enhancement of microbial colonization of the gastrointestinal tract
CA2205773A1 (en)	1996-06-21	1997-12-21	Kraft Foods, Inc.	Creamy, thick, hot beverage foam
EP0821885B2 (en)	1996-07-31	2006-06-07	"Raffinerie Tirlemontoise", société anonyme:	Fructan- and/or polydextrose-containing dairy powders, process for preparing same and their use
FR2752381B1 (fr) *	1996-08-13	1998-11-06	Pierre Moreau	Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
JP3792309B2 (ja)	1996-08-30	2006-07-05	サントリー株式会社	不飽和脂肪酸含有油脂の製造方法
GB9619660D0 (en)	1996-09-20	1996-11-06	Scient Hospital Suppl Int Ltd	Prevention of gastrointestinal damage
JPH10108647A (ja) *	1996-10-08	1998-04-28	Meiji Seika Kaisha Ltd	胃切除術後患者用ミネラル補給材
EP0941088B1 (en)	1996-11-05	2003-03-05	Wisconsin Alumni Research Foundation	Use of conjugated linoleic acid to enhance natural killer lymphocyte function
JP4008974B2 (ja)	1996-12-12	2007-11-14	森永乳業株式会社	ビフィズス菌増殖促進組成物及びその用途
AUPO430496A0 (en)	1996-12-19	1997-01-23	Arnott's Biscuits Limited	Prebiotics and probiotics
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
DK1039892T3 (da) *	1997-02-21	2004-08-30	Univ Tennessee Res Foundation	Anvendelse af polyumættede fedtsyrer til reducering af forekomsten af nekrotiserende enterocolitis
US5840361A (en) *	1997-04-09	1998-11-24	Beech-Nut Nutrition Corporation	Fructan-containing baby food compositions and methods therefor
ATE297994T1 (de)	1997-04-11	2005-07-15	Calgene Llc	Verfahren und zusammensetzungen für die synthese von langkettigen, mehrfach ungesättigten fettsäuren in pflanzen.
NL1005809C2 (nl) *	1997-04-14	1998-10-19	Dsm Nv	Poederverfbindmiddelsamenstelling.
US5846569A (en) *	1997-06-20	1998-12-08	Creative Labs, Inc.	Colostrum supplement
US6051260A (en) *	1998-04-07	2000-04-18	Healthcomm International, Inc.	Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
GB9808579D0 (en)	1998-04-22	1998-06-24	Novartis Nutrition Ag	Improvements in or relating to organic compounds
EP0958825A1 (en)	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
FR2781673B1 (fr)	1998-07-28	2001-09-28	Univ Picardie	Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
US6231889B1 (en) *	1998-09-21	2001-05-15	Chronorx, Llc	Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) *	1998-10-19	2004-09-21	New Nordic Danmark Aps	Composition comprising extensin and, optionally, pectic polysaccharides
PT1148789E (pt) *	1999-01-28	2005-01-31	Nestle Sa	Creme em po soluvel aromatizado
EP1074181A1 (en) *	1999-08-03	2001-02-07	Societe Des Produits Nestle S.A.	Foaming creamer ingredient and powders containing it
DE19940011B4 (de)	1999-08-24	2009-04-02	Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte	Alginataufbereitung und deren Verwendung
US6737089B2 (en) *	1999-08-27	2004-05-18	Morinda, Inc.	Morinda citrifolia (Noni) enhanced animal food product
EP1062873A1 (en)	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de) *	2000-02-16	2001-08-23	Nutricia Nv	Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) *	2000-04-12	2005-01-25	Mid-America Commercialization Corporation	Traditional snacks having balanced nutritional profiles
US6596302B2 (en)	2000-04-13	2003-07-22	Abbott Laboratories	Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
EP1155627A1 (en)	2000-05-18	2001-11-21	Belovo Eggs & Egg Products	Eggs with balanced lipid composition
DE10027050A1 (de)	2000-06-02	2001-12-13	Karim Balan	Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) *	2000-08-11	2002-07-30	Global Health Sciences, Inc.	Low-carbohydrate high-protein creamer powder
US6592863B2 (en) *	2000-08-22	2003-07-15	Nestec S.A.	Nutritional composition
US7491518B2 (en)	2000-08-30	2009-02-17	Amano Enzyme Inc.	Method of elevating yield of oligosaccharides containing α-galactosyl and anti-candida compositions
CN1111541C (zh)	2000-09-15	2003-06-18	青岛海洋大学	一种聚甘露糖醛酸硫酸盐
US20050238655A1 (en)	2004-01-06	2005-10-27	Paul Stamets	Antiviral activity from medicinal mushrooms
US20020119928A1 (en)	2000-10-27	2002-08-29	Mcanalley Bill H.	Dietary supplement compositions
EP1208792A1 (de) *	2000-11-17	2002-05-29	Haag-Streit Ag	Vorrichtung und Verfahren zur Untersuchung und/oder Behandlung eines Auges
DE10057976B4 (de)	2000-11-22	2005-02-03	Südzucker AG Mannheim/Ochsenfurt	Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) *	2000-12-13	2003-01-28	Novartis Nutrition Ag	Infant formula with free amino acids and nucleotides
FI109602B (fi) *	2001-01-25	2002-09-13	Valio Oy	Probioottiyhdistelmä
WO2002060283A2 (en)	2001-01-30	2002-08-08	Unilever N.V.	Food product comprising protein coated gas microbubbles
EP1228694A1 (en)	2001-02-02	2002-08-07	Societe Des Produits Nestle S.A.	Aromatizing agent
CN1457357A (zh) *	2001-02-15	2003-11-19	旭电化工业株式会社	包含β－葡聚糖的制品
EP1243273A1 (en)	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
JP3814494B2 (ja) *	2001-04-27	2006-08-30	松下電器産業株式会社	色管理装置及び色管理システム
DE10136260B4 (de)	2001-07-25	2004-07-08	Südzucker AG Mannheim/Ochsenfurt	Inulin in Geliermittelzusammensetzungen
NL1018832C2 (nl)	2001-08-27	2003-03-03	Friesland Brands Bv	Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel.
JP2003146887A (ja)	2001-11-07	2003-05-21	Gotoo Corporation:Kk	Ｎｋ細胞活性化作用を有する製剤および飲食品
WO2003093322A2 (en)	2002-04-30	2003-11-13	The Population Council, Inc.	Carrageenan based antimicrobial compositions
US6623954B1 (en)	2002-05-28	2003-09-23	Neose Technologies, Inc.	Process for removal of phosphorous from a dairy stream
BRPI0311909A8 (pt)	2002-06-19	2018-02-06	Nutricia Nv	Métodos para a manufatura de uma composição, e para aumentar a capacidade de metilação de um indivíduo, e, composição farmacêutica ou nutricional
EP1374878A1 (en)	2002-06-20	2004-01-02	N.V. Nutricia	Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
EP1538924B1 (en)	2002-08-30	2007-09-26	Campina B.V.	Foaming ingredient and products containing the ingredient
US20040087490A1 (en)	2002-09-20	2004-05-06	Troup John P.	Nutritional compositions
US20040122105A1 (en) *	2002-09-20	2004-06-24	Griscom Bettle	Transdermal compositions
US6974841B1 (en) *	2002-09-27	2005-12-13	Rapisarda Family Irrevocable Trust	Pet anti-aging wellness supplement
GB0229015D0 (en)	2002-12-12	2003-01-15	Novartis Nutrition Ag	New Compound
US20040219188A1 (en) *	2003-05-02	2004-11-04	Comer Gail M.	Composition and methods for nutritional management of patients with hepatic disease
US20070110849A1 (en)	2003-06-23	2007-05-17	Marie-Christine Secretin	Infant or follow-on formula
CA2530437C (en)	2003-06-23	2011-11-15	Nestec S.A.	Nutritional formula for optimal gut barrier function
EP1491570A1 (en)	2003-06-25	2004-12-29	DSM IP Assets B.V.	Powder coating composition for low temperature cure
AU2003904192A0 (en) *	2003-08-11	2003-08-21	Adelaide Research and Innovaiton Pty Ltd	Method for inhibiting bacterial colonisation
CN101987107A (zh)	2003-10-24	2011-03-23	努特里奇亚有限公司	免疫调节性寡糖
DE602004017885D1 (de)	2003-10-24	2009-01-02	Nutricia Nv	Symbiotische zusammensetzung für kleinkinder
FR2866203B1 (fr)	2004-02-13	2006-12-08	Roquette Freres	Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en)	2004-05-17	2005-11-23	Nutricia N.V.	Synergism of GOS and polyfructose
US8252769B2 (en) *	2004-06-22	2012-08-28	N. V. Nutricia	Intestinal barrier integrity
PL1758469T5 (pl) *	2004-06-22	2014-01-31	Nutricia Nv	Poprawa integralności bariery u pacjentów z HIV przez zastosowanie kwasów tłuszczowych
EP1721611A1 (en)	2005-04-21	2006-11-15	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
EP1723951A1 (en)	2005-04-21	2006-11-22	N.V. Nutricia	Nutritional supplement with oligosaccharides for a category of HIV patients
AU2005269887A1 (en)	2004-07-07	2006-02-09	The General Hospital Corporation	Direct activation of ATIII in whole blood and plasma
WO2006007676A1 (en)	2004-07-21	2006-01-26	Amazônia Fitomedicamentos Ltda.	Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
JP4653465B2 (ja)	2004-10-25	2011-03-16	泰信小林	ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
PL1871181T5 (pl)	2005-04-21	2017-10-31	Nutricia Nv	Suplement odżywczy dla pacjentów z HIV
US20070036840A1 (en) *	2005-07-27	2007-02-15	Jose Antonio Matji Tuduri	Phosphorylated glucomannan polysaccharides containing 1-6 and 1-2 linkages increase weight gain in swine
ATE424756T1 (de)	2005-07-29	2009-03-15	Alcon Refractive Horizons Inc	Seitenpositionierungssystem einer ophthalmischen vorrichtung und entsprechende verfahren
US20070231449A1 (en)	2006-03-30	2007-10-04	Nutracea	Non-starchy rice bran polysaccharides
WO2009096772A1 (en) *	2008-02-01	2009-08-06	N.V. Nutricia	Composition for stimulating natural killer cell activity
US9281963B2 (en) *	2008-12-23	2016-03-08	Persistent Systems Limited	Method and system for email search

2004
- 2004-06-06 US US11/571,122 patent/US8252769B2/en active Active
- 2004-06-22 BR BRPI0418921-3A patent/BRPI0418921A/pt not_active Application Discontinuation
- 2004-06-22 PL PL07108969T patent/PL1815755T3/pl unknown
- 2004-06-22 AU AU2004320743A patent/AU2004320743B2/en not_active Expired
- 2004-06-22 RU RU2007102085/10A patent/RU2402240C2/ru active
- 2004-06-22 CN CN200480043417A patent/CN100589712C/zh not_active Expired - Lifetime
- 2004-06-22 EP EP09158304.7A patent/EP2100520B1/en not_active Revoked
- 2004-06-22 PT PT07108969T patent/PT1815755E/pt unknown
- 2004-06-22 ES ES09158304T patent/ES2431363T3/es not_active Expired - Lifetime
- 2004-06-22 DK DK04748674T patent/DK1672987T3/da active
- 2004-06-22 SI SI200431140T patent/SI1815755T1/sl unknown
- 2004-06-22 PL PL09158304T patent/PL2100520T3/pl unknown
- 2004-06-22 AT AT04748674T patent/ATE363213T1/de active
- 2004-06-22 JP JP2007517980A patent/JP4903695B2/ja not_active Expired - Lifetime
- 2004-06-22 DK DK09158304.7T patent/DK2100520T3/da active
- 2004-06-22 PT PT91583047T patent/PT2100520E/pt unknown
- 2004-06-22 PT PT04748674T patent/PT1672987E/pt unknown
- 2004-06-22 ES ES07108969T patent/ES2323988T3/es not_active Expired - Lifetime
- 2004-06-22 CA CA2570205A patent/CA2570205C/en not_active Expired - Lifetime
- 2004-06-22 DE DE602004006765T patent/DE602004006765T2/de not_active Expired - Lifetime
- 2004-06-22 EP EP04748674A patent/EP1672987B1/en not_active Revoked
- 2004-06-22 WO PCT/NL2004/000444 patent/WO2005122790A1/en active Application Filing
- 2004-06-22 ES ES04748674T patent/ES2285484T3/es not_active Expired - Lifetime
- 2004-06-22 NZ NZ552166A patent/NZ552166A/en not_active IP Right Cessation
- 2004-06-22 DE DE602004020813T patent/DE602004020813D1/de not_active Expired - Lifetime
- 2004-06-22 UA UAA200613595A patent/UA81875C2/uk unknown
- 2004-06-22 AT AT07108969T patent/ATE429155T1/de active
- 2004-06-22 PL PL04748674T patent/PL1672987T3/pl unknown
- 2004-06-22 DK DK07108969T patent/DK1815755T3/da active
- 2004-06-22 EP EP07108969A patent/EP1815755B1/en not_active Revoked
2005
- 2005-06-22 ZA ZA200700138A patent/ZA200700138B/en unknown
2009
- 2009-07-14 CY CY20091100740T patent/CY1109224T1/el unknown
2012
- 2012-08-24 US US13/594,147 patent/US9084433B2/en not_active Expired - Lifetime
2015
- 2015-06-15 US US14/739,850 patent/US10499676B2/en not_active Expired - Lifetime
2019
- 2019-12-07 US US16/706,725 patent/US11076623B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ATE429155T1 (de)	2009-05-15
UA81875C2 (uk)	2008-02-11
US8252769B2 (en)	2012-08-28
PL2100520T3 (pl)	2014-01-31
EP1815755B1 (en)	2009-04-22
CN100589712C (zh)	2010-02-17
RU2402240C2 (ru)	2010-10-27
EP2100520A2 (en)	2009-09-16
WO2005122790A1 (en)	2005-12-29
JP4903695B2 (ja)	2012-03-28
CA2570205C (en)	2012-10-30
PL1815755T3 (pl)	2009-09-30
SI1815755T1 (sl)	2009-08-31
ES2431363T3 (es)	2013-11-26
AU2004320743A1 (en)	2005-12-29
PT1815755E (pt)	2009-09-03
ES2323988T3 (es)	2009-07-28
US20130053340A1 (en)	2013-02-28
DE602004020813D1 (de)	2009-06-04
CA2570205A1 (en)	2005-12-29
JP2008503568A (ja)	2008-02-07
US20170042197A9 (en)	2017-02-16
US9084433B2 (en)	2015-07-21
CY1109224T1 (el)	2014-07-02
RU2007102085A (ru)	2008-07-27
AU2004320743B2 (en)	2010-04-08
PT2100520E (pt)	2013-11-06
US20160073669A1 (en)	2016-03-17
PT1672987E (pt)	2007-09-11
EP1815755A1 (en)	2007-08-08
ATE363213T1 (de)	2007-06-15
NZ552166A (en)	2010-05-28
PL1672987T3 (pl)	2007-10-31
US20080064656A1 (en)	2008-03-13
EP1672987A1 (en)	2006-06-28
DK1815755T3 (da)	2009-06-02
CN1997290A (zh)	2007-07-11
DE602004006765D1 (de)	2007-07-12
EP2100520A3 (en)	2009-11-25
EP2100520B1 (en)	2013-07-31
DK2100520T3 (da)	2013-10-28
US20200281241A1 (en)	2020-09-10
US10499676B2 (en)	2019-12-10
ZA200700138B (en)	2008-05-28
ES2285484T3 (es)	2007-11-16
DE602004006765T2 (de)	2008-01-24
BRPI0418921A (pt)	2007-11-27
US11076623B2 (en)	2021-08-03
EP1672987B1 (en)	2007-05-30

Publication	Publication Date	Title
DK1672987T3 (da)	2007-10-01	Forbedring af tarmens barriereintegritet
WO2007058538A3 (en)	2008-06-12	Composition with docosapentaenoic acid
DK1758469T3 (da)	2009-12-21	Forbedring af barriereintegritet i HIV-patienter ved anvendelse af fedtsyrer
NZ600167A (en)	2014-06-27	Concentrated therapeutic phospholipid compositions
CR20120167A (es)	2012-08-21	Conjugados de niacina y ácidos grasos y sus usos
EE200300599A (et)	2004-02-16	Koensüüm Q ja EPA või muu asendamatu rasvhape
MX338247B (es)	2016-04-07	Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
WO2008033643A3 (en)	2008-12-11	Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
AR059089A1 (es)	2008-03-12	Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
PL2164520T3 (pl)	2020-04-30	Cyklodekstryny do podawania kwasów tłuszczowych w tabletkach
SMAP200700061A (it)	2007-12-28	Trattamento delle malattie epatiche in cui il ferro svolge un ruolo nella patogenesi
WO2010044585A3 (en)	2010-07-29	Piperidine compounds, pharmaceutical composition comprising the same and its use
EP1818327A4 (en)	2010-02-24	ALICYCLIC EPOXY (METH) ACRYLATES, PROCESS FOR THEIR PREPARATION AND COPOLYMERS
EP2167071A4 (en)	2013-01-02	BACLOFEN SOLUTION FOR LOW VOLUME THERAPEUTIC DELIVERY
BRPI0514567A (pt)	2008-06-17	aparelho e método para aumentar a solubilidade de oxigênio na água e produto resultante
PL1498119T3 (pl)	2007-01-31	Zastosowanie sprzężonych dienów kwasu linolowego do leczenia przeziębienia
FR2894772B1 (fr)	2008-03-14	Procede d'enrichissement en dha
DK1863570T3 (da)	2011-06-20	Synergistisk varmestabilt oliemedium med eicosapentaensyre (EPA) og decosahexaensyre (DHA)
FR2903604B1 (fr)	2008-09-05	Composition comprenant un retinoide et du peroxyde de benzoyle
AP2008004516A0 (en)	2008-06-30	Docosahexaenoic acid (DHA) producing thraustochytrid strain-SC1
WO2009114090A3 (en)	2009-12-10	Method for inhibiting the build-up of arterial plaque by administering fullerenes
MX2009012458A (es)	2009-12-02	Forma de dosificacion oral que permite una rapida absorcion de un farmaco.
CL2009001458S1 (es)	2010-05-07	Estructura formada por un panel vertical rectangular, un panel base transversal al panel vertical formado por una base sobre la cual se eleva verticalmente hasta los dos tercios de la altura del panel vertical, un marco de contorno rectangular con ambas caras frontal y posterior cubiertas por un panel liso.(solicitud divisional 2990-06)